These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 17382827)

  • 1. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial.
    Marson AG; Al-Kharusi AM; Alwaidh M; Appleton R; Baker GA; Chadwick DW; Cramp C; Cockerell OC; Cooper PN; Doughty J; Eaton B; Gamble C; Goulding PJ; Howell SJ; Hughes A; Jackson M; Jacoby A; Kellett M; Lawson GR; Leach JP; Nicolaides P; Roberts R; Shackley P; Shen J; Smith DF; Smith PE; Smith CT; Vanoli A; Williamson PR;
    Lancet; 2007 Mar; 369(9566):1000-15. PubMed ID: 17382827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors for time to treatment failure and time to 12 months of remission for patients with focal epilepsy: post-hoc, subgroup analyses of data from the SANAD trial.
    Bonnett L; Smith CT; Smith D; Williamson P; Chadwick D; Marson AG
    Lancet Neurol; 2012 Apr; 11(4):331-40. PubMed ID: 22377180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.
    Marson AG; Al-Kharusi AM; Alwaidh M; Appleton R; Baker GA; Chadwick DW; Cramp C; Cockerell OC; Cooper PN; Doughty J; Eaton B; Gamble C; Goulding PJ; Howell SJ; Hughes A; Jackson M; Jacoby A; Kellett M; Lawson GR; Leach JP; Nicolaides P; Roberts R; Shackley P; Shen J; Smith DF; Smith PE; Smith CT; Vanoli A; Williamson PR;
    Lancet; 2007 Mar; 369(9566):1016-26. PubMed ID: 17382828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial.
    Marson AG; Appleton R; Baker GA; Chadwick DW; Doughty J; Eaton B; Gamble C; Jacoby A; Shackley P; Smith DF; Tudur-Smith C; Vanoli A; Williamson PR
    Health Technol Assess; 2007 Oct; 11(37):iii-iv, ix-x, 1-134. PubMed ID: 17903391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Sudell M; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012065. PubMed ID: 31233229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
    Marson A; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton C; Hughes DA; Williamson P; Baker GA; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE;
    Lancet; 2021 Apr; 397(10282):1363-1374. PubMed ID: 33838757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gabapentin monotherapy for epilepsy: A review.
    Ziganshina LE; Abakumova T; Hoyle CHV
    Int J Risk Saf Med; 2023; 34(3):243-286. PubMed ID: 37393439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
    Nolan SJ; Marson AG; Weston J; Tudur Smith C
    Cochrane Database Syst Rev; 2015 Aug; (8):CD001911. PubMed ID: 26275105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
    French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ;
    Neurology; 2004 Apr; 62(8):1261-73. PubMed ID: 15111660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxcarbazepine versus phenytoin monotherapy for epilepsy.
    Muller M; Marson AG; Williamson PR
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003615. PubMed ID: 16625587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamotrigine versus carbamazepine monotherapy for epilepsy.
    Gamble CL; Williamson PR; Marson AG
    Cochrane Database Syst Rev; 2006 Jan; (1):CD001031. PubMed ID: 16437428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
    Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
    Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
    Nolan SJ; Marson AG; Weston J; Tudur Smith C
    Cochrane Database Syst Rev; 2015 Jul; (7):CD001904. PubMed ID: 26204241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxcarbazepine versus carbamazepine monotherapy for partial onset seizures.
    Koch MW; Polman SK
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006453. PubMed ID: 19821367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregabalin monotherapy for epilepsy.
    Zhou Q; Zheng J; Yu L; Jia X
    Cochrane Database Syst Rev; 2012 Oct; 10():CD009429. PubMed ID: 23076957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
    French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ;
    Neurology; 2004 Apr; 62(8):1252-60. PubMed ID: 15111659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Marson AG; Tudur Smith C
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD001911. PubMed ID: 31318037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality-of-life outcomes of initiating treatment with standard and newer antiepileptic drugs in adults with new-onset epilepsy: findings from the SANAD trial.
    Jacoby A; Sudell M; Tudur Smith C; Crossley J; Marson AG; Baker GA;
    Epilepsia; 2015 Mar; 56(3):460-72. PubMed ID: 25630353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study protocol for a pragmatic randomised controlled trial comparing the effectiveness and cost-effectiveness of levetiracetam and zonisamide versus standard treatments for epilepsy: a comparison of standard and new antiepileptic drugs (SANAD-II).
    Balabanova S; Taylor C; Sills G; Burnside G; Plumpton C; Smith PEM; Appleton R; Leach JP; Johnson M; Baker G; Pirmohamed M; Hughes DA; Williamson PR; Tudur-Smith C; Marson AG
    BMJ Open; 2020 Aug; 10(8):e040635. PubMed ID: 32847927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.